Company · CIK 1802768
Royalty Pharma plc
| CIK | 1802768 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | X0 |
| Business address | NY |
| Listed | RPRX (Nasdaq) |
| First annual or quarterly report | 2020-08-12 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-279905 | 2024-06-03 | 2024-06-04 | 3 | |
| 333-257883 | 2021-07-14 | 2021-07-19 | 3 | |
| 333-249454 | 2020-10-13 | 2020-10-19 | 3 | |
| 333-238632 | 2020-05-22 | 2020-06-17 | 6 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-06-04 | 424B5Shelf takedown | 333-279905 | 0001193125-24-154374 |
| 2024-06-03 | 424B5Shelf takedown | 333-279905 | 0001193125-24-152536 |
| 2024-06-03 | S-3ASRShelf registered | 333-279905 | 0001193125-24-152416 |
| 2021-07-19 | 424B5Shelf takedown | 333-257883 | 0001193125-21-218727 |
| 2021-07-15 | 424B5Shelf takedown | 333-257883 | 0001193125-21-215892 |
| 2021-07-14 | S-3ASRShelf registered | 333-257883 | 0001193125-21-214712 |
| 2021-07-07 | EFFECTDeclared effective | 333-257188 | 9999999995-21-002664 |
| 2020-10-19 | 424B4Final prospectus | 333-249454 | 0001193125-20-272071 |
| 2020-10-15 | EFFECTDeclared effective | 333-249454 | 9999999995-20-002871 |
| 2020-10-13 | S-1Registration filed | 333-249454 | 0001193125-20-268436 |
| 2020-09-29 | DRSDraft made public | 377-03605 | 0000950123-20-009990 |
| 2020-06-17 | 424B4Final prospectus | 333-238632 | 0001193125-20-171165 |
| 2020-06-15 | EFFECTDeclared effective | 333-238632 | 9999999995-20-001426 |
| 2020-06-11 | S-1/AAmendment | 333-238632 | 0001193125-20-166398 |
| 2020-06-08 | S-1/AAmendment | 333-238632 | 0001193125-20-162827 |
| 2020-06-02 | S-1/AAmendment | 333-238632 | 0001193125-20-158651 |
| 2020-05-22 | S-1Registration filed | 333-238632 | 0001193125-20-150246 |
| 2020-02-13 | DRSDraft made public | 377-03047 | 0000950123-20-001958 |